Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (251-260 of 379) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2005
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study GroupAndreas Josting, Lucia Nogová, Jeremy Franklin, et al.
BMC Cancer|June 18, 2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trialLutz van Heek, Colin Stuka, Helen Kaul, et al.
British Journal of Haematology|December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphomaStefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study GroupHans Theodor Eich, Susanne Staar, Axel Gossmann, et al.
Frontiers in Oncology|June 11, 2021
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-PatientsJohannes Rosenbrock, Andrés Vásquez-Torres, Horst Mueller, et al.
The Cochrane Database of Systematic Reviews|September 17, 2019
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studiesAngela Aldin, Lisa Umlauff, Lise J Estcourt, et al.
Leukemia & Lymphoma|June 25, 2019
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphomaChristian Baues, Helen Görgen, Robert Semrau, et al.
Blood|October 8, 2005
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivoElke Pogge von Strandmann, Hinrich P Hansen, Katrin S Reiners, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphomaStephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Journal of the National Cancer Institute|May 18, 2006
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patientsJulia Bohlius, Jayne Wilson, Jerome Seidenfeld, et al.
Pageof 38

Showing results (251-260 of 379) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2005
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study GroupAndreas Josting, Lucia Nogová, Jeremy Franklin, et al.
BMC Cancer|June 18, 2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trialLutz van Heek, Colin Stuka, Helen Kaul, et al.
British Journal of Haematology|December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphomaStefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study GroupHans Theodor Eich, Susanne Staar, Axel Gossmann, et al.
Frontiers in Oncology|June 11, 2021
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-PatientsJohannes Rosenbrock, Andrés Vásquez-Torres, Horst Mueller, et al.
The Cochrane Database of Systematic Reviews|September 17, 2019
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studiesAngela Aldin, Lisa Umlauff, Lise J Estcourt, et al.
Leukemia & Lymphoma|June 25, 2019
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphomaChristian Baues, Helen Görgen, Robert Semrau, et al.
Blood|October 8, 2005
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivoElke Pogge von Strandmann, Hinrich P Hansen, Katrin S Reiners, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphomaStephen M Ansell, Steven M Horwitz, Andreas Engert, et al.
Journal of the National Cancer Institute|May 18, 2006
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patientsJulia Bohlius, Jayne Wilson, Jerome Seidenfeld, et al.
Pageof 38